Brean Capital Downgrades Xylem (XYL) to Hold
Brean Capital downgraded Xylem (NYSE: XYL) from Buy to Hold. The downgrade follows disappointing Q2 results.
"Xylem's 2Q13 EPS ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
"Xylem's 2Q13 EPS ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
